Patents by Inventor Sujan Shresta

Sujan Shresta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240400620
    Abstract: The present application relates to compositions of matter, processes and uses of compositions of matter relating to Coronavirus proteins, peptides and epitopes, for example, for therapeutic or preventative vaccination against one or more Coronavirus species, subspecies, or strains, and/or for inducing, enhancing, or sustaining an immune response against at least one Coronavirus serotype or species. The Coronavirus may be, for example, SARS-CoV-2, SARS-COV, MERS-COV, OC43, or any coronavirus, including the betacoronaviruses.
    Type: Application
    Filed: October 14, 2022
    Publication date: December 5, 2024
    Inventor: Sujan Shresta
  • Publication number: 20240156939
    Abstract: The present application relates to composition of matter, processes and use of composition of matter relating to flavivirus peptides and epitopes, for example, for therapeutic or preventative vaccination against a flavivirus, and/or for inducing, enhancing, or sustaining an immune response against a flavivirus, and/or for detecting an infection with or an exposure to a flavivirus in a subject. The flavivirus may be for example the Zika and/or Dengue virus.
    Type: Application
    Filed: September 15, 2023
    Publication date: May 16, 2024
    Inventor: Sujan SHRESTA
  • Patent number: 11806393
    Abstract: The present application relates to composition of matter, processes and use of composition of matter relating to flavivirus peptides and epitopes, for example, for therapeutic or preventative vaccination against a flavivirus, and/or for inducing, enhancing, or sustaining an immune response against a flavivirus, and/or for detecting an infection with or an exposure to a flavivirus in a subject. The flavivirus may be for example the Zika and/or Dengue virus.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: November 7, 2023
    Assignee: La Jolla Institute for Allergy and Immunology
    Inventor: Sujan Shresta
  • Publication number: 20230149526
    Abstract: The present application relates to composition of matter, processes and use of composition of matter relating to flavivirus proteins, peptides, and epitopes, for example, for therapeutic or preventative vaccination against one or more flavivirus serotypes or species, and/or for inducing, enhancing, or sustaining an immune response against at least one flavivirus serotype or species. The flavivirus may be for example the Zika and/or Dengue virus.
    Type: Application
    Filed: June 15, 2022
    Publication date: May 18, 2023
    Inventors: Sujan SHRESTA, Jason GREENBAUM
  • Publication number: 20200237892
    Abstract: The present application relates to composition of matter, processes and use of composition of matter relating to flavivirus peptides and epitopes, for example, for therapeutic or preventative vaccination against a flavivirus, and/or for inducing, enhancing, or sustaining an immune response against a flavivirus, and/or for detecting an infection with or an exposure to a flavivirus in a subject. The flavivirus may be for example the Zika and/or Dengue virus.
    Type: Application
    Filed: August 9, 2019
    Publication date: July 30, 2020
    Inventor: Sujan Shresta
  • Patent number: 10308689
    Abstract: Dengue virus (DV) peptides, including T cell epitopes, structural and non-structural (NS) polypeptide sequences, subsequences and modifications thereof, nucleotide sequences encoding such peptides, and compositions including such peptides and encoding nucleotide sequences, and cells expressing such peptides, are provided. Such DV peptides, nucleotide sequences and compositions, can be used to elicit, stimulate, induce, promote, increase, enhance or activate an anti-DV CD8+ T cell response or an anti-DV CD4+ T cell response. Such peptides, nucleotide sequences and compositions can also be used for and in methods of vaccination/immunization of a subject against Dengue virus (DV) (e.g., to provide protection against DV infection and/or pathology), and for treatment of a subject in need thereof, for example, treatment of the subject for a Dengue virus (DV) infection or pathology.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: June 4, 2019
    Assignee: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Sujan Shresta, Lauren Yauch, Alessandro Sette, Daniela Weiskopf
  • Publication number: 20160130305
    Abstract: Dengue virus (DV) peptides, including T cell epitopes, structural and non-structural (NS) polypeptide sequences, subsequences and modifications thereof, nucleotide sequences encoding such peptides, and compositions including such peptides and encoding nucleotide sequences, and cells expressing such peptides, are provided. Such DV peptides, nucleotide sequences and compositions, can be used to elicit, stimulate, induce, promote, increase, enhance or activate an anti-DV CD8+ T cell response or an anti-DV CD4+ T cell response. Such peptides, nucleotide sequences and compositions can also be used for and in methods of vaccination/immunization of a subject against Dengue virus (DV) (e.g., to provide protection against DV infection and/or pathology), and for treatment of a subject in need thereof, for example, treatment of the subject for a Dengue virus (DV) infection or pathology.
    Type: Application
    Filed: July 15, 2015
    Publication date: May 12, 2016
    Inventors: Sujan Shresta, Lauren Yauch, Alessandro Sette, Daniela Weiskopf
  • Publication number: 20150150960
    Abstract: The invention provides uses, methods and compositions for eliciting, stimulating, inducing, promoting, increasing, or enhancing an anti-Dengue virus T cell response in a subject.
    Type: Application
    Filed: June 25, 2012
    Publication date: June 4, 2015
    Applicant: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventor: Sujan Shresta
  • Publication number: 20110150914
    Abstract: The invention relates to Dengue virus (DV) peptides and compositions thereof, and methods that employ Dengue virus (DV) peptides and compositions thereof. The invention includes among other things, methods of treating Dengue virus (DV) infection or pathology, which include, for example, administering Dengue virus (DV) peptide T cell epitope, to treat a Dengue virus (DV) infection or pathology. The invention includes among other things Dengue virus (DV) vaccination and immunization methods.
    Type: Application
    Filed: June 9, 2009
    Publication date: June 23, 2011
    Applicant: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Sujan Shresta, Laurene E. Yauch, Alessandro Sette